Catheter Ablation for Atrial Fibrillation on Uninterrupted Warfarin: NEED it be Done WITH ECHO Guidance?
ALAN CHENG M.D.,
ALAN CHENG M.D.
Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutes, Baltimore, Maryland, USA
Search for more papers by this authorALAN CHENG M.D.,
ALAN CHENG M.D.
Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutes, Baltimore, Maryland, USA
Search for more papers by this authorAddress for correspondence: Alan Cheng, M.D., 600 N. Wolfe Street, Carnegie 568, Baltimore, MD 21287, USA. Fax: 410-502-0231; E-mail: [email protected]
J Cardiovasc Electrophysiol, Vol. 22, pp. 271-273, March 2011.
No disclosures.
References
- 1 Spragg DD, Dalal D, Cheema A, Scherr D, Chilukuri K, Cheng A, Henrikson CA, Marine JE, Berger RD, Dong J, Calkins H: Complications of catheter ablation for atrial fibrillation: Incidence and predictors. J Cardiovasc Electrophysiol 2008; 19: 627-631.
- 2 Oral H, Chugh A, Özaydin M, Good E, Fortino J, Sankaran S, Reich S, Igic P, Elmouchi D, Tschopp D, Wimmer A, Dey S, Crawford T, Pelosi F, Jongnarangsin K, Bogun F, Morady F: Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006; 114: 759-765.
- 3 Dorbala S, Cohen AJ, Hutchinson LA, Menchavez-Tan E, Steinberg JS: Does radiofrequency ablation induce a prethrombotic state J Cardiovasc Electrophysiol 1998; 9: 1152-1160.
- 4 Andries LJ, Kaluza G, De Keulenaer GW, Mebazaa A, Brutsaert DL, Sys SU: Endocardial endothelial dysfunction and heart failure. J Card Fail 1996; 2: S195-S202.
- 5 Wazni OM, Rossillo A, Marrouche NF, Saad EB, Martin DO, Bhargava M, Bash D, Beheiry S, Wexman M, Potenza D, Pisano E, Fanelli R, Bonso A, Themistoclakis S, Erciyes D, Saliba WI, Schweikert RA, Branchmann J, Raviele A, Natale A: Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: Impact of different anticoagulation regiments and importance of intracardiac echo imaging. J Cardiovasc Electrophysiol 2005; 16: 576-581.
- 6 Ren JF, Marchlinski FE, Callans DJ, Gerstenfeld EP, Dixit S, Lin D, Nayak HM, Hsia HH: Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol 2005; 16: 474-477.
- 7 Wazni OM, Beheiry S, Fahmy T, Barrett C, Hao S, Patel D, Di Biase L, Martin DO, Kanj M, Arruda M, Cummings J, Schweikert R, Saliba W, Natale A: Atrial fibrillation ablation in patients with therapeutic international normalized ratio: Comparison of strategies of anticoagulation management in the periprocedural period. Circulation 2007; 116: 2531-2534.
- 8 Hussein AA, Martin DO, Saliba W, Patel D, Karim S, Batal O, Banna M, Williams-Andrews M, Sherman M, Kanj M, Bhargava M, Dresing T, Callahan T, Tchou P, Di Biase L, Beheiry S, Lindsay B, Natale A, Wazni O: Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: A safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm 2009; 6: 1425-1429.
- 9 Schmidt M, Segerson NM, Marschang H, Akoum N, Rittger H, Clifford SM, Brachmann J, Daccarett M, Marrouche NF: Atrial fibrillation ablation in patients with therapeutic international normalized ratios. PACE 2009; 32: 995-999.
- 10 Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, Lakkireddy D, Verma A, Khaykin Y, Hongo R, Hao S, Beheiry S, Pelargonio G, Russo AD, Casella M, Santarelli P, Santangeli P, Wang P, Al-Ahmad A, Patel D, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Cummings JE, Schweikert RA, Lewis WR, Natale A: Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: The impact of periprocedural therapeutic international normalized ratio. Circulation 2010; 121: 2550-2556.
- 11 Kwak JJ, Pak HM, Jang JK, Kim SK, Park JH, Choi JI, Hwang C, Kim YH: Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21: 620-625.
- 12 Muntwyler J, Attenhofer Jost CH, Diefenbacher W, Beer JH, Nikolic R, Amanpour F, Faeh-Gunz A, Naegeli B, Straumann EH, Maurer D, Candinas R, Dang L, Scharf C: Interaction of vitamin K antagonists with heparin affect monitoring by activated clotting times. J Interv Card Electrophysiol 2010; 27: 89-94.
- 13 Ren JF, Marchlinski FE: Utility of intracardiac echocardiography in left heart ablation for tachyarrhythmias. Echocardiography 2007; 24: 533-540.
- 14 Page SP, Siddiqui MS, Finlay M, Hunter RJ, Abrams DJ, Dhinoja M, Earley MJ, Sporton SC, Schilling RJ: Catheter ablation for atrial fibrillation on uninterrupted warfarin: Can it be done without echo guidance J Cardiovasc Electrophysiol 2010; doi:10.1111/j.1540-8167.2010.01910.x.
- 15 Khairy P, Chauvet P, Lehmann J, Lambert J, Macle L, Tanguay JF, Sirois MG, Santoianni D, Dubuc M: Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation 2003; 107: 2045-2050.
Citing Literature
